Alzheimer's Disease Really Three Distinct Subtypes
the Psychiatry Advisor take:
Alzheimer’s disease is actually made up of three different subtypes, a finding that could help in the development of more targeted research and treatment for the neurocognitive disorder.
Dale Bredesen, PhD, of the University of California, Los Angeles’ Easton Laboratory for Neurodegenerative Disease Research, and colleagues, conducted a two-year study involving metabolic testing of 50 people.
The subtypes they identified are: inflammatory, in which markers such as C-reactive protein and serum albumin to globulin ratios are increased; non-inflammatory, in which other metabolic abnormalities are present; and cortical, which primarily affects younger people, does not cause memory loss at first, but individuals tend to lose language skills.
In a paper released last year, Bredesen showed that making lifestyle, exercise and diet changes to improve the body's metabolism reversed cognitive decline in nine out of 10 patients with early Alzheimer's disease .
“The important implications of [these findings] are that the optimal treatment may be different for each group, there may be different causes, and, for future clinical trials, it may be helpful to study specific groups separately,” Bredesen said in a statement.
The next step for the researchers is to figure out whether the subtypes have different underlying causes, and if they respond differently to potential treatments.
The finding could help in the development of more targeted research and treatments for the neurocognitive disorder.
Alzheimer's disease, long thought to be a single disease, really consists of three distinct subtypes, according to a UCLA study.
The finding could lead to more highly targeted research and, eventually, new treatments for the debilitating neurological disorder, which robs people of their memories.
The study further found that one of the three variations, the cortical subtype, appears to be fundamentally a different condition than the other two, said Dr. Dale Bredesen, the study's author, a UCLA professor of neurology and member of the Easton Laboratory for Neurodegenerative Disease Research.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of ADHD Relatively Stable Over Time Despite Increase in Diagnoses
- Prevalence of Major Depressive Disorder Remains High In US Population
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Evidence of Methylphenidate Abuse: Characterizing Patterns of Use in Pediatric and Adult Populations
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- Most Patients Comfortable With Clinicians Asking About Sexual Orientation
- Peer-to-Peer Depression Awareness Program May Be Beneficial
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders